A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma

NCT05644379 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy

Interventions

DRUG: Cadonilimab Injection
DRUG: Regorafenib

Sponsor

Tianjin Medical University Cancer Institute and Hospital